Alembic debuts 2 generics
Alembic is introducing two generic products.
The company is launching chlorpromazine hydrochloride tablets, 10 mg, 25 mg, 50 mg, 100 mg and 200 mg, which are the generic of Upsher-Smith’s chlorpromazine hydrochloride tablets.
Chlorpromazine hydrochloride tablets are indicated for the management of manifestations of psychotic disorders; and increased mortality in elderly patients with dementia-related psychosis.
Alembic’s generic chlorpromazine hydrochloride tablets come in 100-ct. bottles.
[Read more: Alembic intros generic Perforomist]
Alembic also is rolling out brimonidine tartrate and timolol maleate ophthalmic solution, 0.2%/0.5%, which is the generic of AbbVie’s Combigan Ophthalmic Solution.
Brimonidine tartrate and timolol maleate ophthalmic solution, 0.2%/0.5% is an alpha-adrenergic receptor agonist with a beta-adrenergic receptor inhibitor indicated for the reduction of elevated intraocular pressure in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy.
Alembic will offer generic Combigan in dosages of 5 ml, 10 ml and 15 ml bottles.